论文部分内容阅读
哮喘是机体对抗原性或非抗原性刺激引起的一种气管—支气管反应性过度增高的疾病。其病因和发病机制十分复杂,且至今尚未完全明了。慢性支气管炎是指气管、支气管粘膜及其周围组织的慢性非特异性炎症,和哮喘一样是严重危害人民健康的常见病。典型病例两者鉴别不难。但哮喘并发慢支和/或肺气肿则难区别。临床上哮喘患者或慢支患者在综合治疗的基础上加用肝素治疗,可取得较好疗效,这就促使我们对哮喘和慢喘支患者进行血浆纤溶酶活性和纤维蛋白原的测定,并对其结果进行分析。
Asthma is a disease of the trachea-bronchial hyperresponsiveness caused by the body against antigenic or non-antigenic stimuli. The etiology and pathogenesis is very complicated, and has not yet fully understood. Chronic bronchitis is chronic non-specific inflammation of the trachea, bronchial mucosa and surrounding tissues, and is a common disease that, as asthma, seriously affects people’s health. The identification of the two typical cases is not difficult. However, asthma complicated with chronic bronchitis and / or emphysema is difficult to distinguish. Clinically asthma patients or patients with chronic bronchitis on the basis of comprehensive treatment with heparin therapy can achieve better efficacy, which prompted us to asthma and chronic asthma patients with plasma fibrinolytic activity and fibrinogen determination, and Analyze its result.